Aclaris is a Pennsylvania-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of immuno-inflammatory diseases...
Read moreAclaris is a Pennsylvania-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of immuno-inflammatory diseases...
Read more2012
PublicIndependent CompanyNASDAQACRS
Annual Revenue
$29.8M
Aclaris's revenue is the ranked 1st among it's top 10 competitors. The top 10 competitors average 11.5M. Over the last four quarters, Aclaris's revenue has grown by 433.6%. Specifically, in Q4 2022's revenue was $7.8M; in Q3 2022, it was $19M; in Q2 2022, it was $1.5M; in Q1 2022, Aclaris's revenue was $1.5M.